7 completed, 3 unknown. 6 Not applicable, 2 Phase 3, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Completed 6 |
| Phase 3 | 2 | Unknown 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Inosine Pranobex: new trials by email Literature Review of Inosine Pranobex trials Research Report on Inosine Pranobex
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19 Levamisole, Isoprinosine, Levamisole and Isoprinosine - Coronavirus Disease (COVID-19) | Phase 3 | Unknown | Ain Shams University | 100 | 2020-05-20 | 2020-05-05 |
| Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial Levamisole and isoprinosine, Azithromycin and hydroxychloroquine - Respiratory Tract Infections | Phase 3 | Unknown | Cairo University | 60 | 2020-05-05 | 2020-05-13 |
| Isoprinosine in HIV Patients With Viral Load > 50 y < 200 Copies/mL Metisoprinol - HIV Infections | Phase 4 | Unknown | Universidad San Francisco de Quito | 60 | 2019-02-28 | 2019-12-23 |
| A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Immunodepressed Patients With Uncomplicated Generalized Lymphadenopathy Inosine pranobex - Lymphatic Disease, HIV Infections | Not applicable | Completed | Newport Pharmaceuticals International | 2005-06-24 | ||
| A Study of Isoprinosine in Patients With Severe AIDS Inosine pranobex - HIV Infections | Not applicable | Completed | Newport Pharmaceuticals International | 2005-06-24 | ||
| A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Patients With AIDS Related Complex (ARC) Inosine pranobex - HIV Infections | Not applicable | Completed | Newport Pharmaceuticals International | 2005-06-24 | ||
| The Safety and Effectiveness of Isoprinosine in Patients With Weakened Immune Systems and Lymph Node Disease Inosine pranobex - Lymphatic Disease, HIV Infections | Not applicable | Completed | Newport Pharmaceuticals International | 2005-06-24 | ||
| A Double-Blind Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in Immunodepressed Volunteers Inosine pranobex - HIV Infections | Not applicable | Completed | Newport Pharmaceuticals International | 2005-06-24 | ||
| A Study of Isoprinosine in Patients With Lymph Node Disease Inosine pranobex - Lymphatic Disease, HIV Infections | Not applicable | Completed | Newport Pharmaceuticals International | 2005-06-24 | ||
| A Phase I/II Trial of Ribavirin (With Escalation) + Isoprinosine in Asymptomatic HIV-Viremic Patients Inosine pranobex, Ribavirin - HIV Infections | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 20 | 2008-08-26 |
HIV Infections (8) · AIDS-Related Complex (7) · Acquired Immunodeficiency Syndrome (5) · Lymphatic Diseases (3) · COVID-19 (2) · AIDS-Related Opportunistic Infections (1) · Homosexuality (1) · Neoplasms (1) · Respiratory Tract Infections (1)
Newport Pharmaceuticals International (6) · Ain Shams University (1) · Cairo University (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Universidad San Francisco de Quito (1)
United States (7) · Ecuador (1) · Egypt (1)
Enrique Teran, MD, PhD (1) · Mohamed El Darouti, Professor (1) · Schulof RS (1)